160782 Results for: "1,2,4-Triazole&pageNo=12"

Supplier: Merck

Dithiothreitol (DTT, Cleland's reagent), Sigma-Aldrich®

Supplier: Thermo Fisher Scientific

Iron(III) citrate hydrate 98%

Supplier: MP Biomedicals

Activators: Ca²⁺ is required. Inhibitors: Metal chelating agents such as cysteine, EDTA or o-phenanthroline but not DFP. It is also inhibited by a2-macroglobulin - a large plasma glycoprotein. The human skin enzyme is inhibited by human serum but granulocyte collagenase is not. Human serum contains a2-macroglobulin and a1-antitrypsin that may inhibit certain collagenases.

Supplier: Abcam

Rabbit monoclonal [EPR23232-14] to Carbonic Anhydrase 1/CA1 - BSA and Azide free (Capture).

Supplier: Apollo Scientific

rel-[(1R,3R)-3-(Aminomethyl)cyclopentyl]carbamic acid 1,1-dimethylethyl ester

Supplier: Abcam

Rabbit monoclonal [EPR23505-13] to Tau (phospho T205) - BSA and Azide free.

Supplier: Abcam

Rabbit monoclonal [EPR23580-16] to Kappa light chain - BSA and Azide free (Detector).

Supplier: Abcam

Rabbit monoclonal [EPR19261-142] to Glycogen synthase 1/GYS1 - BSA and Azide free (Capture).

Supplier: Apollo Scientific

1-(4-Fluorophenoxy)-3-{[4-methyl-5-(trifluoromethyl)-4H-1,2,4-triazol-3-yl]thio}propan-2-ol

Supplier: Abcam

Rabbit monoclonal [EPR23575-230] to Kallikrein 10/K10 - BSA and Azide free (Detector).

Supplier: Abcam

Rabbit monoclonal [EPR25648-13] to PRSS2 + PRSS3/Mesotrypsin - BSA and Azide free.

Supplier: Abcam

Rabbit monoclonal [EPR1568-17] to beta III Tubulin - BSA and Azide free (Detector).

Supplier: Apollo Scientific

(6,7,8,9-Tetrahydro-5h-[1,2,4]triazolo[4,3-a]azepin-3-yl)-acetonitrile 98%

Supplier: Abcam

Rabbit monoclonal [UDD1 15(3)] to LRRK2 (phospho S910).

Supplier: Thermo Fisher Scientific

Appearance: White to off-white Crystalline powder

Supplier: Apollo Scientific

6,7-Dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium perchlorate

Supplier: Abcam

Anti-IL-13 Rat Monoclonal Antibody [clone: 13A] (PE (Phycoerythrin))

Supplier: Thermo Fisher Scientific

Nickel ≥99.995% (metals basis), wire, Puratronic®, annealed, Ø 1.0 mm (0.04 in)

Supplier: Abcam

Rabbit monoclonal [EPR4520-11] to Cleaved Lamin A + C (Asp230).

Supplier: Abcam

Rabbit monoclonal [EPMAYR1-127] to PRKAR1A (phospho S77).

Supplier: Abcam

Mouse monoclonal [14/PKC delta] to PKC delta - BSA and Azide free.

Supplier: Enzo Life Sciences

Produced in E. coli. Human 14-3-3epsilon is fused at the N-terminus to a GST-tag.

Supplier: Apollo Scientific

5-Iodo-3,4-dihydro-2H-1,8-naphthyridine, N1-BOC protected 95%

Supplier: Abcam

Rabbit monoclonal [EPR28416-16] to Cytochrome P450 1A2 - BSA and Azide free.

Supplier: Abcam

Rabbit monoclonal [EPR20923-13] to TGF beta Receptor I - BSA and Azide free.

Supplier: Abcam

APC Rabbit monoclonal [EPR27389-11] to Dnmt3a (mutated R882H).

Supplier: Bioss

Caspase-13 (also designated Evolutionarily related interleukin-1beta converting enzyme ; ERICE) involved in the activation cascade of caspases responsible for apoptosis execution. Might function by either activating some proteins required for cell death or inactivating proteins necessary for cell survival. [subunit] Heterodimer of a small and a large subunit. The two subunits are derived from the precursor sequence by an autocatalytic mechanism or by cleavage by Caspase-8. Mainly expressed in peripheral blood lymphocytes, spleen and placenta. Belongs to peptidase family C14.

Supplier: Biotium

This MAb recognizes a single chain, transmembrane, heavily glycosylated protein of 90-120 kDa, which is identified as CD34. Its expression is a hallmark for identifying pluripotent hematopoietic stem or progenitor cells. Its expression is gradually lost as lineage committed progenitors differentiate. CD34 is a marker of choice for staining blasts in acute myeloid leukemia. In addition, CD34 is expressed by soft tissue tumors, such as solitary fibrous tumor and gastrointestinal stromal tumor. Its expression is also found in vascular endothelium. Additionally, it appears that proliferating endothelial cells express this molecule more than the non-proliferating endothelial cells. Anti-CD34 labels > 85% of angiosarcoma and Kaposi's sarcoma, but with a lower specificity.

Supplier: Biotium

MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50% of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70% of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected.

Supplier: Biotium

MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50% of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70% of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected.